Ozempic Muscle Loss: How to Protect Your Lean Mass While Losing Weight

Weight loss is only part of the story. What you lose matters too. Learn why preserving muscle is essential for long-term health and metabolism, how Ozempic and similar medications can affect lean mass, and how Calocurb's clinically proven approach can help you lose fat while maintaining muscle.

Ozempic Muscle Loss: How to Protect Your Lean Mass While Losing Weight

Key Takeaways

  • Muscle loss on GLP-1 medications is real and well-documented. Across clinical trials of semaglutide, lean mass has accounted for a meaningful proportion of total weight lost.
  • It is not a direct drug effect. It is what happens when substantial calorie restriction is not paired with adequate protein and resistance training.
  • Very large calorie deficits combined with low protein intake are the main driver of lean-mass loss. A more moderate pace matters chiefly because it makes hitting protein targets and staying consistent with training more achievable.
  • Up until recently, the two most common evidence-backed protections were adequate protein (approximately 1.2–1.6 g per kilogram of body weight per day) and regular resistance training. Both are modifiable and accessible.
  • Amarasate®, the active ingredient in Calocurb®, provides an additional proven supporter of muscle during weight loss. It supports natural appetite control by increasing three "stop eating" gut hormones, one of which is also implicated in preserving and repairing skeletal muscle. A recently published 24-week study demonstrated it achieves clinically significant weight loss* while maintaining muscle mass*, though protein and resistance training are additional proven levers for protecting skeletal muscle.

Wegovy®/Ozempic® and Zepbound®/Mounjaro® can deliver results that feel almost too good to be true. For many people, the pounds come off faster and with less daily effort than any approach they have tried before. But weight loss is not the same as fat loss, and the scale cannot tell you what you are actually losing.

On glucagon-like peptide-1 (GLP-1) medications, a meaningful share of the weight that comes off can be lean mass: muscle, not just fat. This is not a hidden flaw or a reason to stop. Some lean-mass loss accompanies almost every significant weight-loss approach. What makes it worth understanding here is that the scale and speed of loss with these medications tends to be larger than most people have experienced before.

The good news is that you don't have to trade a weight problem for a muscle one. Calocurb is a bioceutical supplement that helps you lose weight by increasing three different "stop eating" hormones (including GLP-1), while maintaining muscle mass. You can use it as an alternative to GLP-1 medications, or even in conjunction with them, to make their associated muscle loss more manageable. This guide explains why muscle loss happens, who is most at risk, and exactly what to do about it.

At a glance

Factor What the evidence shows What you can do
Share of weight lost as lean mass ≈25–40% of the weight lost on semaglutide and other GLP-1 medications is lean mass.1,2,3,4 If possible, track body composition — not just scale weight — throughout treatment.
Protein intake ≈1.2–1.6 g/kg/day supports lean mass during a calorie deficit (see Your Guide to Protein). Prioritize protein at every meal; front-load earlier in the day.
Regular exercise training The most evidence-backed tool for preserving muscle during active weight loss. Strength train 2–3 times per week targeting major muscle groups. Include some aerobic training too.
Rate of loss/size of deficit Evidence is mixed about whether rate or level of calorie restriction determines lean-mass loss; while occasional studies associate faster loss with larger lean mass loss, others have not.5,6 Other reviews note that the size of calorie deficit impacts weight loss, but doesn't increase lean mass loss deficits.7,8 Keep the deficit moderate so hitting protein targets and training stay achievable.
Age / lower baseline muscle Adults over 40 and those with lower starting lean mass face greater risk of functional loss. Prioritize protein and training; monitor body composition closely if over 40.
Amarasate (Calocurb) A 24-week study of weight loss in overweight and obese people showed an ~5% weight loss, while muscle mass did not decline at all.9 Consider Calocurb as an alternative or adjunct to GLP-1 medications.

Does Ozempic Cause Muscle Loss?

Yes, and the evidence is consistent. Semaglutide and other GLP-1 medications do not cause muscle loss as a unique pharmacological action. Rather, they produce rapid, substantial weight loss, and during any significant calorie restriction, the body draws on both fat stores and some lean tissue. The effect is not unique to these medications: it accompanies crash diets, bariatric surgery, and other aggressive weight-loss methods, too.10 What is different with newer GLP-1 medications is the magnitude and pace of loss.

Across multiple clinical studies of semaglutide, lean mass has accounted for a meaningful proportion of total weight lost. In the STEP 1 trial, a large double-blind, randomized study of once-weekly injectable semaglutide 2.4 mg, 35% of total weight lost over 68 weeks came from lean mass.11

A systematic review of body composition data across semaglutide studies found lean-mass loss could represent up to 40% of total weight lost.12 Similar patterns were observed across semaglutide studies in type 2 diabetes populations.13

The picture is not uniformly bleak. A small study of oral semaglutide in people with type 2 diabetes found that participants maintained their lean mass over the treatment period, suggesting the extent of lean-mass loss depends on dose, duration, rate of loss, and what the individual is doing alongside the medication.14

For more on how GLP-1 medications work and where natural approaches fit in, see GLP-1 Explained: Natural vs Injectable Approaches to Appetite and Weight Control.

Why Does Ozempic Lead to Muscle Loss?

The mechanism is straightforward. GLP-1 medications suppress appetite powerfully, which creates a significant calorie deficit. In a sustained deficit, the body needs energy from somewhere, and it draws on both fat stores and muscle tissue. The more aggressive the deficit and the lower the protein intake, the more muscle the body tends to break down.

There is a specific challenge with GLP-1 medications that makes this harder to manage: nausea, early fullness, and general fatigue are common side effects, particularly during dose escalation.15 These symptoms make it genuinely difficult to eat enough protein to protect lean mass. Inadequate protein intake, more than the pace of weight loss alone, is a key driver of lean-mass loss during GLP-1 treatment.16

This is why the protective strategies below are more than general wellness advice. They are a direct response to the practical challenges of how these medications work.

Why Losing Muscle Matters More Than You Think

Muscle is far more metabolically active than most people appreciate. It plays a central role in calorie burning, blood sugar regulation, bone strength, and physical function. Losing it has consequences that go beyond the scale.

From a metabolic standpoint, less muscle means a lower resting calorie burn, which makes future fat loss harder and weight regain easier.17,18 If you stop taking the medication and previous eating patterns return, the weight that comes back tends to be fat rather than muscle.19 This is sometimes described as "Ozempic skinny fat": scale weight may look acceptable, but the underlying ratio of fat to muscle has shifted unfavorably, and the conditions for rapid regain are in place.

Functional strength is the other real-world cost, particularly for adults over 40. Muscle weakness affects balance, daily tasks, and the ability to stay active.20 Around 30% of muscle mass is lost between 20 and 80 years; dramatic weight loss speeds this up, so it's been estimated that muscle loss during GLP-1 therapy amounts to around 20 years' loss within just a few years.21

For more context, see Why We Regain Weight After Dieting and How to Prevent It.

Who Is Most at Risk for Muscle Loss on Ozempic?

Some degree of lean-mass loss affects most people taking GLP-1 medications, but several factors raise the risk of more significant loss:

  • Adults over 40, where age-related muscle decline already provides less buffer
  • People with lower baseline muscle mass at the start of treatment
  • Anyone consistently falling short of adequate protein intake is the single most controllable risk factor
  • People who are sedentary or doing little resistance training
  • Those who lose weight very rapidly and struggle to eat enough protein during the fast loss phase

The encouraging reality is that all of these risk factors are modifiable. The strategies below address each one directly.

How to Prevent Muscle Loss on Ozempic

Prioritize Protein

Protein is the first and most important lever for protecting lean mass during weight loss. Dietary protein provides the amino acids the body needs to maintain and repair muscle tissue, and higher protein intake has been shown to preserve lean mass more effectively during a calorie deficit.22

The standard recommended intake of 0.8 g/kg/day was set to prevent deficiency in healthy, weight-stable adults, not to protect muscle during active weight loss. Most current guidance for people losing weight on GLP-1 medications points to a higher target: approximately 1.2–1.6 g/kg/day, distributed across meals with roughly 25–30 g per sitting.23,24,25,26 For adults over 65, targets closer to 2.0 g/kg/day may be recommended.27

On GLP-1 medications, the practical challenge is meeting protein targets when nausea and early satiety suppress appetite. Tactics that help: front-load protein earlier in the day when appetite tends to be higher, use shakes or smoothies when solid food feels unappealing, and build protein-dense options into every meal: eggs, Greek yogurt, fish, lean poultry, legumes, tofu, and whey.

For practical guidance, see Your Guide to Protein and Successful Weight Loss.

Do Resistance Training

Resistance training is the second non-negotiable lever. While both endurance and resistance training preserve muscle mass, resistance training also increases muscle strength.28

Two to three sessions per week targeting major muscle groups is a practical, well-supported frequency.29 Beginners do not need a gym: bodyweight exercises, resistance bands, and free weights all qualify. Consistency matters more than intensity, and starting modest and staying consistent is more valuable than pushing hard and stopping.

One key point: regular exercise is far more effective at preventing muscle loss than at rebuilding muscle after it has already been lost. Starting early in your medication journey, even with modest effort, is more valuable than waiting.

Be Strategic About Your Rate of Loss

The relationship between the speed of weight loss and lean-mass outcomes is more nuanced than commonly assumed. Several randomized controlled trials comparing fast and slow weight loss find little meaningful difference in lean-mass loss when total weight lost is matched.30

What the evidence does support is this: very large calorie deficits actually result in less weight loss, probably because it's harder to stick to them.31 A more moderate pace is helpful mainly because it makes the two proven levers, adequate protein and consistent resistance training, easier to sustain. On GLP-1 medications specifically, aggressive appetite suppression can push protein intake very low. If weight is coming off very rapidly and eating enough protein feels impossible, it is worth discussing the dose with your prescribing clinician.

Track Your Body Composition

You cannot protect what you are not measuring. The scale tells you total weight but gives no information about whether you are losing fat or muscle. Body composition tracking separates fat mass from lean mass and tells you whether your current habits are working.

Options include a DEXA scan (the clinical gold standard), MRI, or a modern multi-frequency bioimpedance device such as an InBody or Evolt machine. Ask your healthcare provider about a baseline assessment at the start of treatment, and a follow-up scan partway through. A decline in lean mass is an early signal to review protein intake and training habits before significant loss accumulates. At-home bioimpedance devices are rapidly improving; while they aren't as accurate as InBody or Evolt machines, they can provide a useful tool that you can use regularly.

Can You Rebuild Muscle Lost on Ozempic?

Yes, and the process is exactly what prevents loss in the first place. Progressive resistance training combined with adequate protein rebuilds muscle over time, regardless of how it was lost. Rebuilding takes longer than losing, which is why protection during treatment is the better strategy, but it is absolutely achievable.

On the research horizon, there is genuine scientific interest in agents that could help rebuild muscle during GLP-1 treatment. One experimental approach involves bimagrumab, a treatment that blocks the body's natural muscle-suppressing signals, specifically activin A and myostatin. In a phase 2 clinical study combining bimagrumab with semaglutide, participants achieved approximately 22% total weight loss, with roughly 93% of that loss coming from fat, compared to approximately 71% fat loss on semaglutide alone.32

Bimagrumab remains experimental and is not currently available outside clinical studies. For now, the accessible and proven levers remain protein and resistance training.

Protecting Muscle When You Taper Off Ozempic

Coming off GLP-1 medication is its own risk window for lean mass. As appetite suppression fades, hunger and cravings tend to return, and when they do, protein intake and training habits can slip at exactly the moment they matter most. Weight regained after stopping GLP-1 medications tends to be predominantly fat, partly because lean mass lost during treatment was never fully rebuilt.33

The most important takeaway: the habits that protect muscle during treatment do not become less important when you stop. They become more important. Keeping protein targets and exercise (both aerobic and resistance training) consistent through the taper, rather than only while on full dose, gives you the best chance of holding your results.

Natural appetite support with Calocurb during this transition can help bridge the gap, making it easier to maintain a protein-friendly eating pattern as the drug clears and appetite returns. For more on what to expect when stopping GLP-1 medications: Injectable Weight Loss Medications: What Happens When You Stop?

A More Moderate Approach to Appetite Control

Protein and resistance training are the proven levers for protecting lean mass. This section makes no claim to the contrary. But the ability to sustain those habits consistently depends heavily on appetite management, and that is where natural appetite support plays a role worth understanding.

Calocurb (Amarasate) is a standardized bitter extract of hop flowers grown in New Zealand. It works by activating bitter taste receptors in the gut, which triggers the body's own release of appetite-regulating hormones, including GLP-1, cholecystokinin (CCK), and peptide tyrosine tyrosine (PYY), rather than introducing a synthetic substitute. The result is appetite control that works with your body's own signaling system. PYY is the hormone that helps maintain and restore skeletal muscle; you can read about the benefits of these three hormones here.

The clinical evidence spans four published human studies. In a crossover meal study in healthy-weight men, a single 500 mg dose increased GLP-1 secretion 640% on baseline and reduced caloric intake by approximately 18%.34 In a 24-hour fasting study in healthy men, Amarasate reduced overall hunger by 20%.35 In healthy adult women, the same extract reduced overall hunger and food cravings during a 24‑hour fast by 30% and 40%, respectively.36

Most recently, a 24-week randomized, double-blind, placebo-controlled trial in 150 overweight and obese adults measured real weight and body-composition outcomes: participants taking Calocurb lost 4.3% of body weight versus 0.5% on placebo, with about 6.5 times the fat loss — and that weight came off as fat, with muscle mass holding steady over the six months.37 If you factor in the slight (2 lb/0.9 kg) muscle gain that occurred in those who received Calocurb, then the adjusted weight loss in that group was 5.3%.38 The full evidence base is available at calocurb.com/pages/science.

Calocurb is plant-based, stimulant-free, and requires no prescription. Taken as one to two capsules approximately one hour before a meal, its effects begin within an hour. A sustainable, protein-friendly approach to appetite, one that does not suppress hunger so aggressively that meeting protein targets becomes impossible, is the context in which Calocurb is most useful alongside the proven muscle-protection habits. See: Calocurb GLP-1 Activator.

For more on appetite support after GLP-1 medications: Why Appetite Support Matters Post-GLP-1.

Natural appetite support

Protect your muscle while you lose weight

Calocurb activates your body's own GLP-1, CCK, and PYY — the hormones that signal fullness — without the GI side effects of pharmaceutical GLP-1 medications. The latest 24-week study showed fat loss with muscle mass maintained.

Shop Calocurb See the science
Calocurb bottle

Frequently Asked Questions

Does Ozempic cause muscle loss?
Yes. Clinical studies consistently show that a meaningful proportion of weight lost on semaglutide comes from lean mass, which includes muscle. Lean-mass loss has accounted for roughly 25–40% of total weight lost in GLP-1 studies. This is not a unique drug effect. It is a consequence of substantial calorie restriction, but the scale and pace of GLP-1-related loss make it more pronounced than typical dieting.
How much muscle do you lose on Ozempic?
It varies by individual, dose, diet, and activity level. Across GLP-1 studies, lean mass has represented roughly 25–40% of total weight lost. In the STEP 1 trial, 35% of the weight lost over 68 weeks was lean mass. People eating adequate protein and exercising consistently may lose significantly less. One study of oral semaglutide found that lean mass was maintained over the treatment period in diabetic patients.
How do you prevent muscle loss while taking Ozempic?
Eat more protein than the standard minimum: aim for approximately 1.2–1.6 g per kilogram of body weight per day. Do regular aerobic and resistance training two to three times per week. These two strategies signal the body to preserve muscle during a calorie deficit. On GLP-1 medications, front-loading protein and using shakes can help close the gap when nausea makes eating difficult.
Does losing weight slowly preserve more muscle?
Not on its own. Several randomized controlled trials comparing fast and slow weight loss, when total weight loss is matched, show little meaningful difference in lean-mass outcomes by rate of loss alone. What drives muscle loss is large deficits combined with inadequate protein, regardless of the size of the calorie deficit. In fact, whether losing weight quickly (say, on a very-low-calorie diet), more slowly (with a moderate calorie deficit), or by choosing certain foods (low fat or high fiber) the proportion of lean mass loss is around 25%. In contrast, on high-protein diets, lean muscle loss is around 11%. Nevertheless, a slower pace can help mainly by making adequate protein intake and consistent resistance training easier to sustain.
Can you rebuild muscle after losing it on Ozempic?
Yes. A regular exercise program that includes endurance training but prioritizes resistance training, combined with adequate protein intake, rebuilds muscle over time. It takes longer than losing it, which is why protecting muscle during treatment is the better strategy. Emerging experimental treatments such as bimagrumab show early promise in research settings but are not yet clinically available.
Is muscle loss on Ozempic permanent?
No. Muscle lost during weight loss can be rebuilt through consistent exercise and adequate protein intake. The greater ongoing risk after stopping GLP-1 medication is that regained weight tends to be fat rather than muscle, worsening body composition over time, the so-called "fat overshoot". Maintaining protein and training habits through and after treatment is the best protection against this.
How do I know if I'm losing muscle or fat on Ozempic?
The scale cannot tell you. Body composition tracking tools such as DEXA scans, MRI, or multi-frequency bioimpedance devices (InBody, Evolt) separate fat mass from lean mass. Consider investing in an at-home device for regular monitoring, but ask your healthcare provider about a baseline assessment at the start of treatment and a follow-up at regular intervals, using professional machines. A decline in lean mass is an early signal to review your protein intake and training.
What is Ozempic "skinny fat"?
Ozempic "skinny fat" describes a situation where scale weight reaches a target thanks to the medication, but the ratio of fat to muscle has shifted unfavorably during treatment. If lean mass is lost faster than fat, strength declines, resting metabolism drops, and the conditions for rapid weight regain are set, even at a lower scale weight. Tracking body composition rather than weight alone is the best way to detect and address this.
Can a natural appetite suppressant help with muscle loss on Ozempic?
Maybe. Protein and exercise (especially resistance training) are the proven protectors of lean mass on GLP-1 medications, but the new evidence that Calocurb maintains muscle mass while causing weight loss opens up new possibilities. In Calocurb's own 24-week trial, weight loss came primarily from fat with muscle mass maintained — but that studied Calocurb on its own, not as a muscle-protector during GLP-1 use, so it isn't evidence that Calocurb prevents Ozempic-related muscle loss. Nevertheless, there may be a role for Calocurb use alongside GLP-1 medications, allowing for a reduction in the prescription dose while continuing to get weight loss benefits — and the muscle-preserving effects of Calocurb. It can also make a sustainable, protein-friendly eating pattern easier to hold, especially through a medication taper-off period.

References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. NEJM. 2021;384(11):989-1002.
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. NEJM. 2022;387(3).
  3. Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-hormone-receptor agonist retatrutide for obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514-526.
  4. Coskun T, Wu Q, Schloot NC, et al. Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial. Lancet Diabetes Endocrinol. 2025;13(8):674-684.
  5. Vink RG, Roumans NJ, Arkenbosch LA, Mariman EC, van Baak MA. The effect of rate of weight loss on long-term weight regain in adults with overweight and obesity. Obesity (Silver Spring). 2016;24(2):321-327.
  6. Chaston TB, Dixon JB, O'Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond). 2007;31(5):743-750.
  7. Willoughby D, Hewlings S, Kalman D. Body composition changes in weight loss: strategies and supplementation for maintaining lean body mass, a brief review. Nutrients. 2018;10(12):1876. Published 2018 Dec 3.
  8. Anyiam O, Abdul Rashid RS, Bhatti A, et al. A systematic review and meta-analysis of the effect of caloric restriction on skeletal muscle mass in individuals with, and without, type 2 diabetes. Nutrients. 2024;16(19):3328. Published 2024 Sep 30.
  9. Walker E, Lo K, Smirk I, et al. Bitter hop nutraceutical stimulates fat mass loss while preserving muscle mass in a cohort of individuals with overweight or obesity receiving diet and exercise advice. Obes Pillars. Published July 17, 2026.
  10. Bikou A, Dermiki-Gkana F, Penteris M, Constantinides TK, Kontogiorgis C. A systematic review of the effect of semaglutide on lean mass: insights from clinical trials. Expert Opin Pharmacother. 2024;25(5):611-619.
  11. McCrimmon RJ, Catarig AM, Frias JP, et al. Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial. Diabetologia. 2020;63(3):473-485.
  12. Volpe S, Lisco G, Fanelli M, et al. Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study. Front Endocrinol (Lausanne). 2023;14:1240263. Published 2023 Sep 13.
  13. Linge J, Birkenfeld AL, Neeland IJ. Muscle mass and glucagon-like peptide-1 receptor agonists: adaptive or maladaptive response to weight loss? Circulation. 2024;150(16):1288-1298.
  14. Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006;84(3):475-482.
  15. Youmshajekian L. New ways to keep from losing muscle on Ozempic. Scientific American. Published May 19, 2026. Accessed July 9, 2026.
  16. Willoughby D, Hewlings S, Kalman D. Body composition changes in weight loss: strategies and supplementation for maintaining lean body mass, a brief review. Nutrients. 2018;10(12):1876. Published 2018 Dec 3.
  17. Kokura Y, Ueshima J, Saino Y, Maeda K. Enhanced protein intake on maintaining muscle mass, strength, and physical function in adults with overweight/obesity: A systematic review and meta-analysis. Clin Nutr ESPEN. 2024;63:417-426.
  18. Carbone JW, Pasiakos SM. Dietary protein and muscle mass: translating science to application and health benefit. Nutrients. 2019;11(5):1136. Published 2019 May 22.
  19. Paddon-Jones D, Leidy H. Dietary protein and muscle in older persons. Curr Opin Clin Nutr Metab Care. 2014;17(1):5-11.
  20. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559.
  21. Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr. 2017;8(3):511-519. Published 2017 May 15.
  22. Lowrie FJ, Rahimi MM, Hogan CM, et al. The impact of exercise on fat free mass reduction during very low energy diet-induced weight loss in adults with overweight or obesity: A systematic review and meta-analysis. Obes Res Clin Pract. 2025;19(5):380-387.
  23. Willoughby D, Hewlings S, Kalman D. Body composition changes in weight loss: strategies and supplementation for maintaining lean body mass, a brief review. Nutrients. 2018;10(12):1876. Published 2018 Dec 3.
  24. Volpe S, Lisco G, Fanelli M, et al. Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study. Front Endocrinol (Lausanne). 2023;14:1240263. Published 2023 Sep 13.
  25. Anyiam O, Abdul Rashid RS, Bhatti A, et al. A systematic review and meta-analysis of the effect of caloric restriction on skeletal muscle mass in individuals with, and without, type 2 diabetes. Nutrients. 2024;16(19):3328. Published 2024 Sep 30.
  26. Kokura Y, Ueshima J, Saino Y, Maeda K. Enhanced protein intake on maintaining muscle mass, strength, and physical function in adults with overweight/obesity: A systematic review and meta-analysis. Clin Nutr ESPEN. 2024;63:417-426.
  27. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559.
  28. Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr. 2017;8(3):511-519. Published 2017 May 15.
  29. Lowrie FJ, Rahimi MM, Hogan CM, et al. The impact of exercise on fat free mass reduction during very low energy diet-induced weight loss in adults with overweight or obesity: A systematic review and meta-analysis. Obes Res Clin Pract. 2025;19(5):380-387.
  30. Volpe S, Lisco G, Fanelli M, et al. Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study. Front Endocrinol (Lausanne). 2023;14:1240263. Published 2023 Sep 13.
  31. Anyiam O, Abdul Rashid RS, Bhatti A, et al. A systematic review and meta-analysis of the effect of caloric restriction on skeletal muscle mass in individuals with, and without, type 2 diabetes. Nutrients. 2024;16(19):3328. Published 2024 Sep 30.
  32. Heymsfield SB, Aronne LJ, Montgomery P, et al. Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. Nat Med. 2026;32(3):869-882.
  33. Willoughby D, Hewlings S, Kalman D. Body composition changes in weight loss: strategies and supplementation for maintaining lean body mass, a brief review. Nutrients. 2018;10(12):1876. Published 2018 Dec 3.
  34. Walker EG, Lo KR, Pahl MC, et al. An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial. Am J Clin Nutr. 2022;115(3):925-940.
  35. Walker E, Lo K, Tham S, et al. New Zealand bitter hops extract reduces hunger during a 24 h water only fast. Nutrients. 2019;11(11):2754.
  36. Walker E, Lo K, Gopal P. Gastrointestinal delivery of bitter hop extract reduces appetite and food cravings in healthy adult women undergoing acute fasting. Obes Pillars. 2024;11:100117.
  37. Walker E, Lo K, Smirk I, et al. Bitter hop nutraceutical stimulates fat mass loss while preserving muscle mass in a cohort of individuals with overweight or obesity receiving diet and exercise advice. Obes Pillars. Published July 17, 2026.
  38. Walker E, Lo K, Smirk I, et al. Bitter hop nutraceutical stimulates fat mass loss while preserving muscle mass in a cohort of individuals with overweight or obesity receiving diet and exercise advice. Obes Pillars. Published July 17, 2026.
Calocurb

Written by

Calocurb

← Back to blog